The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Transfection Technologies Market Through 2030?
The transfection technologies market size has shown significant expansion in recent years. This market is anticipated to rise from $1.31 billion in 2025 to $1.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. The historical growth in this sector was primarily due to increased molecular biology research, advancements in gene expression studies, an escalating need for protein production, enhanced funding for genomics research, and its initial integration into academic laboratories.
The market for transfection technologies is anticipated to experience robust expansion over the coming years. This market is projected to reach $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. Key factors contributing to this expansion during the projected timeframe include the proliferation of cell and gene therapies, the expanding pipelines for RNA therapeutics, an increase in investment within life sciences research, the requirement for effective transfection reagents, and the broader application of personalized medicine. Significant trends expected during this period encompass a growing need for gene editing research instruments, the broadened development of RNA-based therapeutics, enhanced utilization in cell and gene therapy applications, an increase in academic and biomedical research activities, and improvements in non-viral transfection techniques.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp
Which Significant Factors Are Encouraging Growth In The Transfection Technologies Market?
The increasing adoption of gene therapy is anticipated to fuel the expansion of the transfection technologies market in the future. This therapeutic approach targets the treatment or prevention of illnesses through genetic modification, encompassing the insertion, correction, or substitution of defective genes. The growth of gene therapy stems from advancements in genetic research, improved delivery mechanisms, and its efficacy in addressing genetic conditions that were previously untreatable. Transfection technologies play a vital role in gene therapy by enabling the accurate, secure, and efficient introduction of genetic material into cellular structures. These technologies enable both transient and lasting alterations to the genome, which are fundamental for managing genetic disorders and various cancers. An example illustrating this is from December 2024, where the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) authorized six gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the expanding landscape of gene therapy is a significant catalyst for the growth of the transfection technologies market.
How Is The Transfection Technologies Market Structured Across Different Market Segments?
The transfection technologies market covered in this report is segmented –
1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions
What Trends Are Shaping The Transfection Technologies Market Structure?
Key companies within the transfection technologies market are prioritizing the development of advanced technology, such as mechanoporation transfection systems, to enable more intricate and customized applications in both research and therapeutics. Mechanoporation transfection systems function by using mechanical forces to create temporary openings in cell membranes, allowing genetic material to enter cells. This method proves efficient and minimally invasive, leading to better preservation of cell viability. For example, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system consists of a benchtop unit and the CellPore Transfection Kit 300, which includes a specialized reagent kit and single-use delivery cartridges. Employing controlled, rapid deformation in microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cellular disruption and high viability. These characteristics are essential for progressing research and the advancement of cutting-edge cell and gene therapies.
Who Are The Key Market Participants In The Transfection Technologies Market?
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.
Access The Complete Transfection Technologies Market Report:
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report
Which Region Stands As The Largest Contributor To The Transfection Technologies Market?
North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Transfection Technologies Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp
Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company
Transfection Reagents And Equipment Market Report 2026
Gene Delivery Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Sterilization Equipment And Disinfectants Market 2026
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model